Microalgae Production

From Lab to Pilot to Industry

From NOK 100 thousand to NOK 100 mill in 4 years

CEO Roald Audun Flo

Biopharmia AS

The Grand Challanges Can Biotechnology be the Solution?

Climate

Sustainable industry production (white biotech)

Food production (green/blue biotech)

Energy

Bioenergy

Biofuel

Health

Aging population

Healthy (and enough) food (green/blue biotech)

Biopharmia`s Sustainable Business Strategy

Develop, manufacture and implement our sustainable designed and patented Accordion Photobioreactor and Systems for production of microalgae

Technology Licensing, Partnerships, Joint Ventures, others

Extensive R&D and consulting services related to technology, strategies, markets, customrelations, etc.

Markets: Pharma, nutraceuticals, medicine, cosmetica, functional food, human food, animal feed, fishfeed, plastics, chemicals, lubricants, fertiliser, energy, biofuel etc.

Biopharmia

Business Strategy - Time - Markets

High quality products like:

Omega-3, EPA, DHA, AA

(HUFA, PUFA), beta-1,3/1,6-D-

glucan, astaxanthin, vitamins,

minerals, carbohydrates etc.

Ingredients in medicine,

pharmacy, nutraceutical and

cosmetic industries, based on

microalgae

Ingredients for

Aquaculture and Agriculture

industries;

Ingredients in Food,

Beverage, Functional food,

etc. Bioplastic , other

bioproducts, etc. based on

microalgae

Production of energy

(especially for the transport

industry);

Biodiesel «Bio Jet Fuel»,

Ethanol, Hydrogen, etc.,

based on, and produced

from , ae

microalgae

Phase I Phase II Phase III

●

●I

●

Phase I Phase II

Phase III

0 2 4 6 8 10 ● ● ● ● ● ● ● ● ● ●

● Time/year

Profitability/time

Markets Algae Products

International Algae Ingredients Markets

Market Commercialization Propects

Energy – Biofuels/Biodiesel/H2 - 5 - 10 years

CCS - Wastewater etc. R&D needed - Ready

Aquaculture/Agriculture/Food - Ready

Speciality Chemicals/Cosmetics - Ready

Biopharmia Extensive Laboratory Scale R&D

Production Technologies Open Ponds - Photobioreactors

Current PBR Technology Challanges for Industrial Production of Algae

•Energy

•High costs of Materials

•Technology - Design

•Complexity (Labor/Automation)

•Land

•Water

•Nutrients

SOLUTION:

Designing a NOVEL

Low-Cost Algae Photobioreactor Technology for Photoautrophic,

Mixotrophic and Heterotrophic Microalgae Production!

The Patented Accordion Photobioreactor

A vertical series of angled

flat plates

Low-cost

Simple design

Simple maintenance

Lower power requirement

Adjustable light incidence

Adjustable flow

Modular

Ease of scale up

Ease of harvesting

Space Saver

Accordion Photobioreactor Patent no. WO 2011/063129 A2

Biopharmia owns the exclusive world wide rights

Different types

Regular Accordion

Air

Acc

ord

ion

Laboratory

Greenhouse

Day 1 Day 6

Accordion Pilot at The University of Agder - Norway

Production of omega3

DHA/EPA and H2 Three BA-students at Three students at UiA

earned their BA-

degrees at University

of Arizona based on

Accordion

Sponsored by

Biopharmia

Biopharmia`s Algae Production

Plant

Algae Production in Greenhouse – Norway

Partners in Florida – Texas – Arizona – California USA

Saudi Arabia Based on BioPharmia`s technology in algae production

The Philippines Algae production based on BioPharmia`s technology

Biopharmia 2009 - 2012

2009 - : Start with share capital NOK 100.000,-

R&D - Laboratory testing of algae

World Research for PBR Technologies

Exclusive world wide rights of the Accordion PBR

Pilots – Norway – USA - Others

Scaled up Accordion algae production

Partnerships - JV - Licenses - Consulting Services

Market research, development and customer contacts

2012: Biopharmia valued to NOK 110 mill.

No loan – No dept – No grants

Biopharmia Today - Projects

2012 - 2013: New offices - Laboratories - Production

facilities

2012 - 2013: R&D facilities including ca 30.000 m2

areal for pilots, demonstration, etc.

2012 - 2013: Based on our Accordion BPR and produced

samples; Joint Venture for production of

omega-3, DHA - EPA, etc.

2012 - 2013: Based on demonstration/pilot constructions,

obtained projects from 1.000 m2 to 20.000 m2

2012 - 2013: Partnership for production of 100 tons

80% DHA based on our technology etc.

Projects cont.

2012 - 2013: Biopharmia USA, Inc. – Licenses, JV,

Partnerships; A number of projects for

industrial production of omega-3, etc.

2012 - 2013: Saudi Arabia – From pilot to industrial

production based on partnership/JV/

licenses

2012 - 2013: The Philippines – Collaboration, R&D;

From pilot scale to industrial

production, licenses/JV/partnerships

Biopharmia ”The Nature`s Wisdom”

”We are not taking over The Earth from

our forefathers –

We are borrowing it from our children”

Thank you for your attention!

Copyright Biopharmia AS